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The endoscopic injection of Dx/HA in the management of vesicoureteral reﬂux (VUR) has become an accepted alternative to
open surgery. In the current study we evaluated the value of cystography to detect de novo contralateral VUR in unilateral cases of
VUR at the time of Dx/HA injection and correlated the ﬁndings of immediate post-Dx/HA injection cystography during the same
anesthesia to 2-month postoperative VCUG to evaluate its ability to predict successful surgical outcomes. The current study aimed
to evaluate whether an intraoperatively performed cystogram could replace postoperative studies. But a negative intraoperative
cystogram correlates with the postoperative study in only 80%. Considering the 75–80% success rate of Dx/HA implantation,
the addition of intraoperative cystograms cannot replace postoperative studies. In patients treated with unilateral VUR, PIC
cystography can detect occult VUR and prevent postoperative contralateral new onset of VUR.
1.Introduction
The role of endoscopic injection of dextranomer/hyaluronic
acid copolymer (Dx/HA) has expanded, as an alternative
to open surgery, to a treatment option for observation
protocols using prophylactic antibiotics. Deﬂux has been
FDA approved since 2001 as a treatment option for grade
2–4 vesicoureteral reﬂux (VUR) in single systems with no
accompanying urological malformations in children above
one year of age. The operative ease of technique, short
procedure, and recovery time as well as repeatability of
injections have popularized the technique with surgeons and
parents alike. Reports of expanded use to patients of all ages
and grades of VUR even in the presence of duplication,
ureterocele, or other lower tract anomalies are published
worldwide [1, 2]. In a statement of the AUA board of
directors from October 2007, it was determined that: “It is
the current position of the American Urological Association
that endoscopic injection of the dextranomer/hyaluronic
compound Deﬂux is an option in the management of
pediatric vesicoureteral reﬂux (VUR)” [3, 4].
The initial success rate was quoted as 68% [5] and is still
mentioned on the current website [6] of the manufacturing
company (Q-MED, Scandinavia Inc). In the meantime,
the original subureteric injection technique (STING) has
evolved to the intraureteric injection technique intro-
duced by the Atlanta group. Using this hydrodistention-
implantation technique (HIT), the authors reported success
rates of 89% [7]. However, the reported worldwide success
rates diﬀer considerably (55%–89% [7, 8]). Unpublished
data from our institution show an overall radiographic
success rate of 75% for patients and 84% for renal units
after the ﬁrst injection. These numbers include all grades of
VUR and a variety of urological malformations. Although
the success rates continuously improve, the numbers of most
institutions still diﬀer signiﬁcantly from the traditional 98%
for open reimplants. Since up to 25% of patients will have
remaining VUR after Dx/HA injection, we still perform
voiding cystograms 2 months after surgery.
Positional instillation of contrast (PIC) cystography was
developed to detect occult VUR in patients with recurrent
urinary tract infections (UTI) after a negative standard2 International Journal of Nephrology
Figure 1: Positive unilateral HPC after Deﬂux injection showing
residual VUR.
voiding cystogram. It has a higher sensitivity than standard
voiding cystogram (VCUG) and can detect occult VUR
[9]. Parents can be advised that in case of a positive
PIC, Dx/HA injection can be performed during the same
anesthesia. In the current study, we compared two diﬀerent
PIC techniques and evaluated two diﬀerent scenarios: First,
whether PIC cystography or high-pressure cystograms were
useful to detect de novo contralateral VUR in the case
of preoperative unilateral VUR and second, whether PIC
cystography, when performed intraoperatively immediately
after Dx/HA injection, can predict a successful surgical
outcome by correlating the results with a standard 2-month
postprocedure VCUG.
2.MaterialandMethods
A retrospective chart review was performed on all intraop-
erative cystograms performed at the time of Dx/HA injec-
tions at our institution from 2005–2007. IRB approval was
obtained. Dx/HA injections were performed for all grades of
VURandincludedcomplexcasessuchasduplicatedsystems.
In case of preoperative unilateral reﬂux, a PIC cystogram
was performed on the contralateral unaﬀected side before
Dx/HA injection. If positive, bilateral injection took place.
If negative, only the aﬀected side was treated. The injections
were done using the HIT technique as described by Kirsch
et al. [7]. Dx/HA was injected until a suﬃcient mound
and good ureteral coaptation was observed. At this point a
cystogramwasperformed.Twotechniquesforintraoperative
cystograms were studied. The ﬁrst group underwent a high-
pressure cystogram (Figure 1). The outﬂow portion of the 10
french oﬀ set cystoscope (Wolf, Germany) was placed at the
bladder neck ﬁlling the bladder with contrast material (Cys-
tograﬁn) to 100cm water pressure until voiding occurred
around the cystoscope ensuring complete bladder ﬁlling.
The second group underwent standard PIC cystography [8]
with the outﬂow portion of the cystoscope directed at the
ureteral oriﬁce at a 100cm water pressure for 5 seconds
(Figure 2).Radiographicviewsforbothtestswereperformed
in anterior-posterior and lateral as well as upper tract views.
The intraoperative cystogram was noted to be positive if any
grade of VUR was present (Figure 3). In cases of a positive
Figure 2: Negative unilateral PIC cystogram after Deﬂux injection
showing resolution of VUR.
Figure 3: Positive unilateral positional infusion contrast (PIC)
cystogram before Deﬂux injection showing de novo VUR.
study on the contralateral side or for remaining VUR after
injection, Dx/HA was reinjected. The cystogram was then
repeated until resolution of the VUR was seen. The patients
were left on prophylactic antibiotics and followed up at 4
weeks postoperatively with an ultrasound and 2 months
postoperatively with a VCUG. The correlations of the intra-
and postoperative study as well as the detection of de novo
VUR were noted.
3. Results
Altogether 116 patients and 177 renal units (RU) were
treated and available for evaluation. Out of the 116 patients,
34 were found preoperatively to have unilateral and 82
bilateral VUR. New contralateral VUR (de novo) for the
34 preoperative unilateral reﬂuxing patients was found
intraoperatively in 27 RU (Figure 4(c)). The high-pressure
intraoperative cystogram (Group 1) was performed in 86
RUs and the standard PIC (Group 2) in 91 RUs. There was
no statistically signiﬁcant diﬀerence between groups 1 and 2
for the detection of de novo VUR (Figure 4(b)).
Forbothgroups,only5RUwerefoundtohaveremaining
VUR intraoperatively after Dx/HA injection (2 in Group
1 and 3 in Group 2). All 5 patients were reinjected
and had a subsequent negative intraoperative cystogram.International Journal of Nephrology 3
Follow up
Negative RUS
(n = 116)
(RU = 177)
VCUG
Positive
(n = 28)
(RU = 36)
Negative VCUG
(n = 88)
(RU = 141)
(a)
Deﬂux
(n = 116) (RU = 177)
(unilateral = 55)
(bilateral = 61)
HPC
(RU=86)
Negative
HPC
(RU = 84)
Positive
HPC
(RU = 2)
PIC
(RU = 91)
Negative
PIC
(RU = 88)
Positive
PIC
(RU = 3)
(b)
VUR (n = 116)
Unilateral VUR
(n = 34)
PIC
Negative
(n = 7)
Positive
(n = 27)
Bilateral VUR
(n = 82)
(c)
Figure 44 International Journal of Nephrology
No intra- or postoperative complications were noted. No
patient had a UTI in the follow-up period. Postoperative
pain management, if necessary, consisted of Ibuprofen or
Acetaminophen according to parental preference. In all
patients,thepostoperativeUSatfourweekswerenegativefor
hydronephrosis or any other new abnormality. The Dx/HA
deposits were seen in the bladder in all cases. At 2 months
postoperative standard VCUG detected 20 RU (23%) to be
positive for VUR in Group 1 and 16 RU (18%) positive for
V U Ri nG r o u p2 .A l t o g e t h e r3 6R Uw e r ep o s i t i v e ,f o ra n
allover success rate of 80% for RU and 75% for patients
(Figure 4(a)). There was no statistical diﬀerence between the
groups. The grade of VUR, age and gender of patient as well
as amount of Deﬂux injected did not inﬂuence the result.
4. Discussion
Vesicoureteral reﬂux remains a common disease, and espe-
ciallyforlowergradestheprospectofspontaneousresolution
is good. But, the data on the value of daily prophylactic
antibiotics remain controversial, and most parents are con-
cerned about their long-term use. The discussion becomes
evident by the current multi-institutional NIH-funded
RIVUR study, which aims to evaluate the role of prophylactic
antibiotic in VUR. In addition to prolonged antibiotic use,
parents and patients alike dread the yearly necessary voiding
cystogram to check for resolution. Therefore, to avoid the
daily antibiotics and the yearly VCUG, many parents con-
sider surgical treatment options. The endoscopic injection of
Dx/HA is an attractive management alternative for parents.
When presenting the surgical options, all parents are enthu-
siastic about the minimal invasive nature of the procedure
with low complication possibilities and fast recovery times.
However, the 20%–25% lower success rate of the endoscopic
procedure in comparison to the open surgery is a concern.
Although Dx/HA can be reinjected, it requires further
testing,anesthesia,andtimespentawayfromschoolorwork.
Therefore, it would be highly desirable to develop a method
to check the success of the Deﬂux injection intraoperatively.
PICcystographyisusedtodetectoccultVURinpatientswith
a negative standard voiding study who suﬀer from recurrent
UTIs. According to Rubenstein et al., the procedure is a
100% sensitive and 91% speciﬁc in identifying VUR and
can, therefore, detect occult VUR [9]. Tareen et al. recently
conﬁrmed the ﬁndings in 5 patients [10]. In a study on
39 patients with febrile UTIs and negative voiding studies
from4diﬀerentinstitutions,PICcystogramswereperformed
and VUR identiﬁed in 82% of these patients. Additionally,
the authors noted that oriﬁces that were patulous, laterally
displaced, or positive for hydrodistention were much more
likely to be positive for VUR than normal oriﬁces [11].
Pinto et al. also performed intraoperative PIC cystograms
and found that 23% of patients had a positive, postoperative
VCUG despite a negative intraoperative PIC study [12], and
Palmer conﬁrmed these results [13]. The authors concluded
that PIC cystography was not useful to raise the success rate
of Deﬂux injection.
In the current study, we used two diﬀerent cystogram
techniques: the standard PIC study and a high-pressure
cystogram, ﬁlling the bladder until irrigation ﬂuid leaked
around the cystoscope. Even with this aggressive cystogram
technique only an 80% correlation between a negative
intraoperative cystogram and postoperative cystogram was
achieved. The success rate of 75% for patients and 80% for
RU could not be improved. Several reasons for the intra-
operative negative study are possible. At time of injection a
relative wound edema might increase the coaptation of the
ureteral oriﬁce, temporarily giving a negative intraoperative
study result. Other possibilities include decrease in the size
of the injected Dx/HA deposit over time, also thought to be
responsible for long-term failure after Dx/HA injection [14].
Finally,Dx/HAdepositscanmigratefromtheirinjectedposi-
tion. This phenomenon has been noted during cystoscopy
at the time of the planned second injection of Deﬂux after
initial failure. The Dx/HA deposits tend to migrate medially
and toward the bladder neck causing long-term failure of
injection.
Elmore et al. reported the onset of new contralateral
VUR after Dx/HA implantation in approximately 13% of
126 patients with preoperatively unilateral VUR [15]. In the
current study, 34 out of 116 patients were preoperatively
diagnosed with unilateral VUR only. Twenty seven of
these 34 patients demonstrated a positive PIC cystography
intraoperatively and were successfully injected with Dx/HA.
None of these de novo detected reﬂuxing units were positive
for VUR in the postoperative cystograms.
5. Conclusion
A negative intraoperative cystogram correlates with the post-
operative VCUG in only 80%. Considering that the success
rates of Dx/HA injections are commonly between 75–80%,
the addition of intraoperative cystograms cannot replace
postoperative studies. In patients treated with unilateral
VUR, PIC cystography can detect occult reﬂux and prevent
postoperative contralateral new onset of VUR.
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